What is the weight in grams of a Qvar (beclomethasone dipropionate) 40 microgram inhaler?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Qvar 40 mcg Inhaler Weight Specification

The Qvar 40 mcg inhaler canister weight is not specified in the available clinical evidence, as pharmaceutical guidelines and research focus on dosing per actuation (micrograms per puff) rather than total canister weight in grams.

Understanding Qvar Formulation

  • Qvar is a hydrofluoroalkane-134a (HFA) formulation of beclomethasone dipropionate that delivers 40 mcg or 80 mcg per actuation, depending on the strength 1
  • The HFA-BDP formulation provides equivalent efficacy to older chlorofluorocarbon formulations at approximately half the dose 1
  • Each canister contains beclomethasone dipropionate combined with absolute ethanol and HFA propellant 2

Clinical Dosing Context

  • For adults and children ≥5 years, the low daily dose range for beclomethasone HFA 40 mcg/puff is 80-240 mcg total daily dose (2-6 puffs), medium dose is >240-480 mcg (>6-12 puffs), and high dose is >480 mcg (>12 puffs) 3
  • The typical canister contains either 100 or 120 actuations, though this varies by manufacturer and is not consistently documented in clinical guidelines 3

Why Weight Information Is Not Clinically Relevant

  • Clinical guidelines universally specify inhaled corticosteroid dosing in micrograms per day rather than total canister weight, as therapeutic decisions are based on delivered dose per actuation 3, 4
  • The total weight of the canister (including propellant, actuator, and medication) does not inform clinical decision-making for asthma management 3

Practical Recommendation

Contact the manufacturer (3M Pharmaceuticals) or check the product packaging insert for exact canister weight specifications, as this information is proprietary and not included in clinical practice guidelines.

References

Research

Asthma management with HFA-BDP (Qvar).

Hospital medicine (London, England : 1998), 1999

Research

Bronchial asthma showing reduction in FEV1 after inhalation of Qvar.

The Journal of asthma : official journal of the Association for the Care of Asthma, 2006

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Inhaled Fluticasone Propionate Dosage and Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.